Efficacy of Octreotide and Sclerotherapy in the Treatment of Acute Variceal Bleeding in Cirrhotic Patients: A Prospective, Multicentric, and Randomized Clinical Trial

References

• References
   Google Scholar
• Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800–9.
   PubMed Web of Science ®Google Scholar
• Conn HO, Grace ND, Bosch J, Groszmann RJ, Rodes J, Wright SC, et al. Propranolol in the prevention of the first haemorrhage from oesophagogastric varices. A multicenter randomized clinical trial. Hepatology 1991; 13: 902–12.
   Google Scholar
• Bosch J, D’Amico G, Luca A, Garcia Pagan JC, Feu F, Escorsell A. Drug therapy for variceal haemorrhage. In: Bosch J, Groszmann RJ, editors. Portal hypertension. Pathophysiology and treatment. London: Blackwell Scientific Publications; 1994. p. 108–23.
   Google Scholar
• Kravetz D, Bosch J, Teres J, Rodes J. Comparison of intravenous somatostatin and vasopressin infusion in the treatment of acute variceal hemorrhage. Hepatology 1984; 4: 442–6.
   PubMed Web of Science ®Google Scholar
• Westaby D, Hayes PC, Gimson ES, Polson RJ, Williams R. Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology 1989; 9: 274–7.
   Google Scholar
• Teres J, Baroni R, Bordas JM, Visa J, Pera C, Rodes J. Randomized trial of portocaval shunt, stapling transection and endoscopic sclerotherapy in uncontrolled variceal bleeding. J Hepatol 1987; 4: 159–67.
   PubMed Web of Science ®Google Scholar
• Avgerinos A, Armonis A, Raptis S. Somatostatin or octreotide versus endoscopic sclerotherapy in acute variceal haemorrhage: a meta-analysis study. J Hepatol 1995; 22: 247–8.
   Google Scholar
• Kutz K, Nüesch E, Rosenthaler J. Pharmacokinetics of SMS 201–995 in healthy subjects. Scand J Gastroenterol 1986; 21 Suppl 119: 65–72.
   PubMed Web of Science ®Google Scholar
• Jenkins SA, Baxter JN, Corbett WA, Shields R. Effects of a somatostatin analogue SMS 201–995 on hepatic hemodynamic in the pig and on intravariceal pressure in man. Br J Surg 1985; 72: 1009–12.
   PubMed Web of Science ®Google Scholar
• Warhen J, Eriksson LS. The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism en healthy subjects and patients with cirrhosis. Scand J Gastroenterol 1986; 21 Suppl 119: 103–8.
   Google Scholar
• Mc Kee R. A study of octreotide in oesophageal varices. Digestion 1990; 45 Suppl: 60–4.
   Google Scholar
• Mc Cormick PA, Dick R, Siringo S, Wagstaff D, Chesta J, McIntyre N, et al. Octreotide reduces azygos blood flow in cirrhotic patients with portal hypertension. Eur J Gastroenterol Hepatol 1990; 2: 489–92.
   Web of Science ®Google Scholar
• Lin HC, Tsai YT, Lee FY, Lee SD, Hsia HC, Lin WJ, et al. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology 1992; 103: 229–34.
   PubMed Web of Science ®Google Scholar
• Nevens F, Van Steenbergen W, Yap SH, Fevery J. Assessment of variceal pressure by continuous non-invasive endoscopic registration: a placebo controlled evaluation of the effect of terlipressin and octreotide. Gut 1996; 38: 129–34.
   PubMed Web of Science ®Google Scholar
• Burroughs AK. Double blind RCT of 5 day octreotide versus placebo, associated with sclerotherapy for trial/failures. International Octreotide Varices Study Group [abstract]. Hepatology 1996; 24: 352A.
   Google Scholar
• Jenkins SA, Copeland G, Kingsworth A, Shields R. A prospective randomized controlled clinical trial comparing sandostatin and injection sclerotherapy in the control of acute variceal haemorrhage: an interim report [abstract]. Gut 1992; 33: F221.
   Google Scholar
• Poo JL, Bosques F, Garduño R, Marin E, Morán MA, Bobadilla J, et al. Octreotide versus emergency sclerotherapy in acute variceal hemorrhage in liver cirrhosis. A randomized, multicenter study [abstract]. Gastroenterology 1996; 110: A1297.
   Google Scholar
• Sung JJ, Chung SCS, Lai CW, Chan FKL, Leung JWC, Yung MY. Octreotide infusion or emergency sclerotherapy for variceal hemorrhage. Lancet 1993; 342: 637–41.
   PubMed Web of Science ®Google Scholar
• De Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson M, Fleig W, et al. Consensus report. Definitions, methodology and therapeutic strategies in portal hypertension: a consensus development workshop. J Hepatol 1992; 15: 256–61.
   Google Scholar
• Navasa M, Bosch J, Chesta J, Bru C, Pizcueta P, García-Pagán JC, et al. Haemodynamic effects of subcutaneous administration of SMS 201–995 a long acting somatostatin analog in patients with cirrhosis and portal hypertension. J Hepatol 1988; 7 Suppl 1: S64.
   Google Scholar
• Zironi G, Rossi C, Siringo S, Galaverni C, Gaiani S, Piscaglia F, et al. Short-and long hemodynamic response to octreotide in portal hypertensive patients: a double-blind, controlled study. Liver 1996; 16: 225–34.
   PubMedGoogle Scholar
• Jenkins SA, Shields R, Davies M, Ellas E, Turbull AJ, Bassendine MF, et al. A multicentre randomized trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage. Gut 1997; 41: 526–33.
   PubMed Web of Science ®Google Scholar
• Planas R, Quer JC, Boix J, Canet J, Armengol M, Cabre E, et al. A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding. Hepatology 1994; 20: 370–5.
   PubMed Web of Science ®Google Scholar
• Shields R, Jenkins SA, Baxter JN, Kingsnorth AN, Ellenbogen S, Makin CA, et al. A prospective randomized controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. J Hepatol 1992; 16: 128–37.
   PubMed Web of Science ®Google Scholar
• Burroughs A, McCormick P, Hughes M, Sprengers D, D’Heygere F, McIntyre N. Randomized, double blind, placebo-controlled trial of somatostatin for variceal bleeding. Gastroenterology 1990; 99: 1388–95.
   Google Scholar
• Fleischer D. Etiology and prevalence of severe persistent upper gastrointestinal bleeding. Gastroenterology 1983; 84: 538–43.
   PubMed Web of Science ®Google Scholar
• Escorsell A, Feu F, García-Pagán JC, Luca A, Bandi JC, Casado M, et al. Hemodynamic effects of octreotide in cirrhotic patients with portal hypertension. A double-blind study [abstract]. J Hepatol 1995; 23 Suppl 1: 85.
   Google Scholar
• Erikssön LS, Brundin T, Soderlund C, Wahren J. Haemodynamic effects of long-acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol 1987; 22: 919–25.
   Google Scholar
• Cello JP, Chan MF. Octreotide therapy for variceal hemorrhage. Digestion 1993; 54 Suppl 1: 20–6.
   PubMed Web of Science ®Google Scholar
• Lin HC, Yang MC-M, Hou M-C, Li SM, Huang Y-T, Yu P-C, et al. Effects of long-term administration of octreotide in portal vein-stenosed rats. Hepatology 1996; 23: 537–43.
   Google Scholar
• Silvain C, Carpentier S, Sautereau D, Czernichow B, Métreau JM, Fort E, et al. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial. Hepatology 1993; 18: 61–5.
   Google Scholar
• Terblanche J, Burroughs AK, Hobbs KEF. Controversies in the management of bleeding esophageal varices. N Engl J Med 1989; 320: 1393–8.
   Google Scholar
• Levacher S, Lefoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat J-L. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995; 346: 865–8.
   Google Scholar
• Avgerinos A, Nevens F, Raptis S, Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomized trial. Lancet 1997; 350: 1495–9.
   PubMed Web of Science ®Google Scholar